by KJ McElrath | Nov 9, 2017 | Opioids |
There are many persons and institutions that bear responsibility for America’s opioid...
by KJ McElrath | Nov 8, 2017 | Invokana |
Patients with Type 2 diabetes who take the prescription medication Invokana (canagliflozin) either...
by KJ McElrath | Nov 7, 2017 | Abilify |
A six-year legal battle has finally ended for drugmakers Bristol-Meyer Squibb (BMS) and Otsuka as...
by KJ McElrath | Nov 3, 2017 | Pharmaceutical Industry |
This could be bad news for Big Pharma, for which sales of antidepressant medications bring in...
by KJ McElrath | Oct 31, 2017 | Pharmaceutical Industry |
Medical science has recognized a third form of diabetes – and Medical researchers in the U.K. are...